MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/bju.16440

Медицинская библиотека · BJU international · 2024

Assessing risk of lymph node invasion in complete responders to neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Flammia Rocco Simone, Tuderti Gabriele, Bologna Eugenio, Minore Antonio, Proietti Flavia, Licari Leslie Claire, Mastroianni Riccardo, Anceschi Umberto, Brassetti Aldo, Bove Alfredo, Misuraca Leonardo, D'Annunzio Simone, Ferriero Maria Consiglia, Guaglianone Salvatore, Chiacchio Giuseppe, De Nunzio Cosimo, Leonardo Costantino, Simone Giuseppe

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

To investigate the lymph node invasion (LNI) rate in patients exhibiting complete pathological response (CR) to neoadjuvant chemotherapy (NAC) and to test the association of CR status with lower LNI and better survival outcomes.

MATERIALS AND

METHODS

We included patients with bladder cancer (BCa; cT2-4a; cN0; cM0) treated with NAC and radical cystectomy (RC) + pelvic lymph node dissection (PLND) at our institution between 2012 and 2022 (N = 157). CR (ypT0) and LNI (ypN+) were defined at final pathology. Univariable and multivariable logistic regression analysis was performed to test the association between CR and LNI after adjusting for number of lymph nodes removed (NLR). Kaplan-Meier and Cox regression analyses were used to assess overall survival (OS), metastasis-free survival (MFS) and disease free-survival (DFS) according to CR status.

RESULTS

Overall CR and LNI rates were 40.1% and 19%, respectively. The median (interquartile range [IQR]) NLR was 26 (19-36). The LNI rate was lower in patients with CR vs those without CR (2 [3.2%] vs 61 [29.8%]; P < 0.001). After adjusting for NLR, CR reduced the LNI risk by 93% (odds ratio 0.07, 95% confidence interval [CI] 0.01-0.25; P < 0.001). Kaplan-Meier plots depicted better 5-year OS (69.7 vs 52.2%), MFS (68.3 vs 45.5%) and DFS (66.6 vs 43.5%) in patients with CR vs those without CR. After multivariable adjustments, CR independently reduced the risk of death (hazard ratio [HR] 0.44, 95% CI 0.24-0.81; P = 0.008), metastatic progression (HR 0.41, 95% CI 0.23-0.71; P = 0.002) and disease progression (HR 0.41, 95% CI 0.24-0.70; P = 0.001).

CONCLUSION

Based on these findings, we postulate that PLND could potentially be omitted in patients exhibiting CR after NAC, due to negligible risk of LNI. Prospective Phase II trials are needed to explore this challenging hypothesis.

Для цитирования: Flammia Rocco Simone, Tuderti Gabriele, Bologna Eugenio, Minore Antonio, Proietti Flavia, Licari Leslie Claire, Mastroianni Riccardo, Anceschi Umberto, Brassetti Aldo, Bove Alfredo, Misuraca Leonardo, D'Annunzio Simone, Ferriero Maria Consiglia, Guaglianone Salvatore, Chiacchio Giuseppe, De Nunzio Cosimo, Leonardo Costantino, Simone Giuseppe. Assessing risk of lymph node invasion in complete responders to neoadjuvant chemotherapy for muscle-invasive bladder cancer.. BJU international. 2024. DOI: 10.1111/bju.16440.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.